|

CYCLACEL PHARMACEUTICALS INC (CYCC)

US23254L6039 - Common Stock

0.2982  +0.01 (+3.18%)

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
370.00K0.000.000.000.00
Operating Expenses
28.94M27.66M22.94M10.64M9.68M
Research and Development
21.51M20.27M15.48M4.76M4.66M
Selling, General, and Administrative Expenses
7.42M7.38M7.46M5.88M5.02M
Operating Income
-28.57M-27.66M-22.94M-10.64M-9.68M
Interest Income/Expense
210.00K440.00K60.00K60.00K330.00K
Other Income/Expense
70.00K1.30M140.00K890.00K230.00K
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-28.26M-25.92M-22.73M-9.68M-9.13M
Income Tax
-4.50M-4.72M-3.85M-1.24M-1.30M
Net Income
-23.97M-21.40M-19.09M-12.42M-8.03M
EBITDA
N/A-27.63M-22.90M-10.62M-9.66M
 
Per Share Data
EPS Diluted Total Ops
-1.92-1.90-2.14-3.42-9.79
Non GAAP EPS
-1.93-1.90-2.14-3.87-10.00
 
Statistics
Profit Margin
-6478.38%N/AN/AN/AN/A
Operating Profit Margin
-7721.62%N/AN/AN/AN/A

All data in USD

Charts